News | March 07, 2024
Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies
Isosorbide mononitrate is used to prevent chest pain (angina) in patients with a certain heart condition (coronary artery disease)
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Gabapentin is indicated for the management of Postherpetic Neuraligia
Synthon will be responsible for obtaining US regulatory approval for Palbociclib Tablets
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
Subscribe To Our Newsletter & Stay Updated
